| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |